{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:25:50Z","timestamp":1774016750558,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"DOI":"10.7759\/cureus.105552","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:29:47Z","timestamp":1774009787000},"source":"Crossref","is-referenced-by-count":0,"title":["Guillain-Barr\u00e9 Syndrome as the Initial Manifestation of Lyme Disease: Diagnostic Challenges"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Elnour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Monem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Ghalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4172\/2327-5073.1000199","article-title":"The development of Guillain-Barre syndrome (GBS) in association with confirmed Lyme disease. A potential autoimmune response in GBS secondary to tick-borne diseases?","volume":"4","author":"Awan SF","year":"2015","unstructured":"Awan SF, Murphy FT. The development of Guillain-Barre syndrome (GBS) in association with confirmed Lyme disease. A potential autoimmune response in GBS secondary to tick-borne diseases?. Clin Microbiol. 2015, 4:1000199. 10.4172\/2327-5073.1000199","journal-title":"Clin Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000499901","article-title":"Atypical Lyme neuroborreliosis, Guillain-Barr\u00e9 syndrome or conversion disorder: differential diagnosis of unusual Neurological Presentations","volume":"11","author":"Teodoro T","year":"2019","unstructured":"Teodoro T, Oliveira R, Afonso P. Atypical Lyme neuroborreliosis, Guillain-Barr\u00e9 syndrome or conversion disorder: differential diagnosis of unusual Neurological Presentations. Case Rep Neurol. 2019, 11:142-7. 10.1159\/000499901","journal-title":"Case Rep Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1052-4","article-title":"Guillain-Barr\u00e9 syndrome risk among individuals infected with Zika virus: a multi-country assessment","volume":"16","author":"Mier-Y-Teran-Romero L","year":"2018","unstructured":"Mier-Y-Teran-Romero L, Delorey MJ, Sejvar JJ, Johansson MA. Guillain-Barr\u00e9 syndrome risk among individuals infected with Zika virus: a multi-country assessment. BMC Med. 2018, 16:67. 10.1186\/s12916-018-1052-4","journal-title":"BMC Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1745.199483","article-title":"Lyme polyradiculitis masquerading Guillain-Barre syndrome","volume":"11","author":"Kumar M","year":"2016","unstructured":"Kumar M, Singh R, Rashid M. Lyme polyradiculitis masquerading Guillain-Barre syndrome. J Pediatr Neurosci. 2016, 11:384-5. 10.4103\/1817-1745.199483","journal-title":"J Pediatr Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7823","article-title":"Guillain-Barre syndrome, neuroborreliosis, or both","volume":"12","author":"Owens J","year":"2020","unstructured":"Owens J, Filatov A, Husain-Wilson S. Guillain-Barre syndrome, neuroborreliosis, or both. Cureus. 2020, 12:e7823. 10.7759\/cureus.7823","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.07.030","article-title":"Clinical association: Lyme disease and Guillain-Barre syndrome","volume":"35","author":"Patel K","year":"2017","unstructured":"Patel K, Shah S, Subedi D. Clinical association: Lyme disease and Guillain-Barre syndrome. Am J Emerg Med. 2017, 35:1583.e1-2. 10.1016\/j.ajem.2017.07.030","journal-title":"Am J Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01432","article-title":"Early Lyme disease-associated Guillain Barre syndrome: a case report","volume":"27","author":"Schrestha K","year":"2022","unstructured":"Schrestha K, Kadkhoda K. Early Lyme disease-associated Guillain Barre syndrome: a case report. IDCases. 2022, 27:e01432. 10.1016\/j.idcr.2022.e01432","journal-title":"IDCases"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43296","article-title":"Lyme disease presenting with interesting neurological features of weakness and hyporeflexia: a case report","volume":"15","author":"Semy M","year":"2023","unstructured":"Semy M, Lee-Kwen P, Semy S. Lyme disease presenting with interesting neurological features of weakness and hyporeflexia: a case report. Cureus. 2023, 15:e43296. 10.7759\/cureus.43296","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42322","article-title":"Neuroborreliosis presenting as Guillain-Barr\u00e9 syndrome","volume":"15","author":"Farr J","year":"2023","unstructured":"Farr J, Bittar J. Neuroborreliosis presenting as Guillain-Barr\u00e9 syndrome. Cureus. 2023, 15:e42322. 10.7759\/cureus.42322","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC recommendation for serologic diagnosis of Lyme disease","volume":"68","author":"Mead P","year":"2019","unstructured":"Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 2019, 68:703. 10.15585\/mmwr.mm6832a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/neurol-india.Neurol-India-D-24-00011","article-title":"Lyme disease as an extremely rare cause of Guillain-Barr\u00e9 syndrome in India","volume":"72","author":"Varma YS","year":"2024","unstructured":"Varma YS, Kumar V, Agarwal K, Biswas R, Adil M. Lyme disease as an extremely rare cause of Guillain-Barr\u00e9 syndrome in India. Neurol India. 2024, 72:1102. 10.4103\/neurol-india.Neurol-India-D-24-00011","journal-title":"Neurol India"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/jnrp.jnrp_96_17R1","article-title":"Respiratory involvement in Guillain-Barre syndrome: the uncharted road to recovery","volume":"8","author":"Garg M","year":"2017","unstructured":"Garg M. Respiratory involvement in Guillain-Barre syndrome: the uncharted road to recovery. J Neurosci Rural Pract. 2017, 8:325-6. 10.4103\/jnrp.jnrp_96_17R1","journal-title":"J Neurosci Rural Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.83087","article-title":"Treatment guidelines for Guillain-Barr\u00e9 syndrome","volume":"14","author":"Meena AK","year":"2011","unstructured":"Meena AK, Khadilkar SV, Murthy JM. Treatment guidelines for Guillain-Barr\u00e9 syndrome. Ann Indian Acad Neurol. 2011, 14:S73-81. 10.4103\/0972-2327.83087","journal-title":"Ann Indian Acad Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkac067.045","article-title":"P45 Lyme-associated uveitis: panuveitis and positive Lyme results - is it a masquerade or the real deal?","volume":"6","author":"Bray L","year":"2022","unstructured":"Bray L, Jeffries M. P45 Lyme-associated uveitis: panuveitis and positive Lyme results - is it a masquerade or the real deal?. Rheumatol Adv Pract. 2022, 6:rkac067.045. 10.1093\/rap\/rkac067.045","journal-title":"Rheumatol Adv Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-19","article-title":"Laboratory diagnosis of Lyme borreliosis","volume":"34","author":"Branda JA","year":"2021","unstructured":"Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021, 34:e00018-19. 10.1128\/CMR.00018-19","journal-title":"Clin Microbiol Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez E","year":"2016","unstructured":"Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016, 315:1767-77. 10.1001\/jama.2016.2884","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa217","article-title":"Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicenter, equivalence, randomized, open-label trial","volume":"72","author":"Kortela E","year":"2021","unstructured":"Kortela E, Kanerva MJ, Puustinen J, et al.. Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicenter, equivalence, randomized, open-label trial. Clin Infect Dis. 2021, 72:1323-31. 10.1093\/cid\/ciaa217","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467640-guillain-barr-syndrome-as-the-initial-manifestation-of-lyme-disease-diagnostic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:29:48Z","timestamp":1774009788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467640-guillain-barr-syndrome-as-the-initial-manifestation-of-lyme-disease-diagnostic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.105552","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}